Answer
Apr 10, 2025 - 08:54 AM
Formoterol, a long-acting beta-agonist (LABA) used to treat asthma and chronic obstructive pulmonary disease (COPD), carries a warning about an increased risk of asthma-related death. It is important to use formoterol in conjunction with an inhaled corticosteroid for asthma treatment to mitigate this risk. Patients should not use formoterol as a monotherapy for asthma.
